http://orcid.org/0000-0003-3321-7225
References
- Harries AD, Dye C. Tuberculosis. Ann Trop Med Parasitol. 2006;100:415–431.
- Calver AD, Murray M, Strauss OJ, et al. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence South Africa. Emerg Infect Dis. 2010;16:264.
- World Health Organization. WHO media centre [Internet]. 2013. Available from: http://www.who.int/mediacentre/factsheets/fs300/en/
- Statistics South Africa. Statistical release P0302 [Internet]. [cited 2016 Nov 15] Available from: http://www.statssa.gov.za/publications/P0302/P03022011.pdf
- DOTS-Plus Guidelines. Revised National Tuberculosis Control Program (RNTCP). Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare; [Internet]. 2010. Available from: http://health.bih.nic.in/Docs/Guidelines/Guidelines-DOTS-Plus.pdf
- Schacht J, Talaska AE, Rybak LP. 2012. Cisplatin and Aminoglycoside Antibiotics: Hearing Loss and Its Prevention. Anat Rec (Hoboken). 295:1837–1850.
- Duggal P, Sarkar M. Audiologic monitoring of multidrug resistant tuberculosis patients on aminoglycoside treatment with long term follow up. BMC Ear Nose Throat Disord. 2007;7:5.
- O’Donnell EP, Scarsi KK, Scheetz MH, et al. Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients. Int J Antimicrob Agents. 2010;36:94–95.
- Saunders JE, Greinwald JH, Vaz S, et al. 2009. Aminoglycoside ototoxicity in Nicaraguan children: patient risk factors and mitochondrial DNA results. Otolaryngol Head Neck Surg. 140:103–107.
- Vaamonde P, Castro C, García-Soto N, et al. Tuberculous otitis media: a significant diagnostic challenge. Otolaryngol Head Neck Surg. 2004;130:759–766.
- Selimoglu E. Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007;13:119–126.
- Reavis KM, Phillips DS, Fausti SA, et al. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss. Ear Hear. 2008;29:875–893.
- Stavroulaki P, Apostolopoulos N, Segas J, et al. Evoked otoacoustic emissions–an approach for monitoring cisplatin induced ototoxicity in children. Int J Pediatr Otorhinolaryngol. 2001;59:47–57.